Evidence map›Paper›PMID 39702732›Full record

ArticleCurrent microbiology2024

Deciphering the Antimicrobial and Antibiofilm Efficiency of Thyme Essential Oil Encapsulated Zeolitic Imidazole Framework-8 Against Foodborne Pathogens.

Suganathan Muthalagu, Suganthy Natarajan

Abstract read
PubMed Publisher
In one paragraph

Article in Current microbiology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Suganathan MuthalaguBionanomaterials Research Lab, Department of Nanoscience and Technology, Alagappa University, Karaikudi, Tamil Nadu, India.
Suganthy NatarajanBionanomaterials Research Lab, Department of Nanoscience and Technology, Alagappa University, Karaikudi, Tamil Nadu, India. suganthyn@alagappauniversity.ac.in.ORCID http://orcid.org/0000-0002-1273-8497

Funding

RUSA-Phase 2.0 grant (Dated: 09.10.2018)RUSA-Phase 2.0 grant Dept. of Edn. Govt. of IndiaRUSA-Phase 2.0 grant (No. F. 24-51/2014-URUSA-Phase 2.0 grant Policy (TN Multi-Gen)
6 · The paper itself

Abstract

Food Packaging using antibacterial substances plays a vital role in food industry in controlling contamination caused by food borne pathogens. Stability and pH dependent degradation characteristics of zeolitic imidazole framework-8 (ZIF-8) makes its suitable candidate for biomedical applications. The present study focuses on thyme essential oil (TEO) encapsulated in ZIF-8 to achieve a synergistic antibacterial effect and prolonged drug release, aiming to extend the shelf life of food products. Optical, structural and surface characterizations of TEO encapsulated within ZIF-8 (ZIF-8@TEO) reveals successful incorporation of TEO into ZIF-8 nanoparticles. High drug loading and pH dependent release rate with higher release rate at acidic condition (75%) makes ZIF-8 a promising drug delivery system. ZIF-8@TEO exhibited potent antimicrobial against Staphylococcus aureus, Bacillus subtilius and Pseudomonas aeruginosa, also attenuated the biofilm forming ability of these food borne pathogens. In vitro and in vivo toxicity studies reveal the non-hemolytic and non-toxic nature indicating its biocompatible nature. The results of the study reveal that ZIF-8@TEO nanoconjugate can be used for the development of novel antibacterial nanocomposite-based films for food packaging applications.

Indexed as

Anti-Bacterial AgentsBiofilmsFoodborne DiseasesOils, VolatileThymus PlantZeolitesAnimalsBacteriaDrug LiberationDynamic Light ScatteringEmbryo, NonmammalianHemolysisHumansImidazolesKineticsMicrobial Sensitivity TestsAnti-Bacterial AgentsimidazoleImidazolesOils, VolatileZeolites

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.